Abstract:According to global prevalence analysis studies, acute upper respiratory tract infections (URTIs) are the most common acute infectious disease in children, especially in preschool children. Acute URTIs lead to an economic burden on families and society. Vitamin A refers to the fat‐soluble compound all‐trans‐retinol and also represents retinol and its active metabolites. Vitamin A interacts with both the innate immune system and the adaptive immune system and improves the host's defences against infections. Correlation studies show that serum retinol deficiency was associated with a higher risk of respiratory tract infections. Therefore, vitamin A supplementation may be important in preventing acute URTIs. To assess the effectiveness and safety of vitamin A supplements for preventing acute upper respiratory tract infections in children up to seven years of age. We searched CENTRAL, MEDLINE, Embase, the Chinese Biomedical Literature Database, and two trial registration platforms to 8 June 2023. We also checked the reference lists of all primary studies and reviewed relevant systematic reviews and trials for additional references. We imposed no language or publication restrictions. We included randomised controlled trials (RCTs), which evaluated the role of vitamin A supplementation in the prevention of acute URTIs in children up to seven years of age. We used the standard methodological procedures expected by Cochrane. We included six studies (27,351 participants). Four studies were RCTs and two were cluster‐RCTs. The included studies were all conducted in lower‐middle‐income countries (two in India, two in South Africa, one in Ecuador, and one in Haiti). Three studies included healthy children who had no vitamin A deficiency, one study included children born to HIV‐infected women, one study included low‐birthweight neonates, and one study included children in areas with a high local prevalence of malnutrition and xerophthalmia. In two studies, vitamin E was a co‐treatment administered in addition to vitamin A. We judged the included studies to be at either a high or unclear risk of bias for random sequence generation, incomplete outcome data, and blinding. Primary outcomes Six studies reported the incidence of acute URTIs during the study period. Five studies reported the number of acute URTIs over a period of time, but there was population heterogeneity and the results were presented in different forms, therefore only three studies were meta‐analysed. We are uncertain of the effect of vitamin A supplementation on the number of acute URTIs over two weeks (risk ratio (RR) 1.00, 95% confidence interval (CI) 0.92 to 1.09; I 2 = 44%; 3 studies, 22,668 participants; low‐certainty evidence). Two studies reported the proportion of participants with an acute URTI. We are uncertain of the effect of vitamin A supplementation on the proportion of participants with an acute URTI (2 studies, 15,535 participants; low‐certainty evidence). Only one study (116 participants) reported adverse events. No infant in either the placebo or vitamin A group was found to have feeding difficulties (failure to feed or vomiting), a bulging fontanelle, or neurological signs before or after vitamin A administration (very low‐certainty evidence). Secondary outcomes Two studies (296 participants) reported the severity of subjective symptoms, presented by the mean duration of acute URTI. Vitamin A may have little to no effect on the mean duration of acute URTI (very low‐certainty evidence). The evidence for the use of vitamin A supplementation to prevent acute URTI is uncertain, because population, dose and duration of interventions, and outcomes vary between studies. From generally very low‐ to low‐certainty evidence, we found that there may be no benefit in the use of vitamin A supplementation to prevent acute URTI in children up to seven years of age. More RCTs are needed to strengthen the current evidence. Future research should report over longer time frames using validated tools and consistent reporting, and ensure adequate power calculations, to allow for easier synthesis of data. Finally, it is important to assess vitamin A supplementation for preschool children with vitamin A deficiency. Background Acute upper respiratory tract infections (URTIs) are the most common acute infectious diseases in children, especially in preschool children. Vitamin A has a positive role in the immune system and may improve the host's defences against infections. Studies show that children with vitamin deficiency are more likely to suffer from respiratory tract infections. Therefore, we assessed the role of vitamin A supplementation in the prevention of acute upper respiratory tract infections in preschool children (up to seven years of age). Review question What is the role of vitamin A supplementation in the prevention of acute URTIs in preschool childr -Abstract Truncated-

The Role of the Micronutrients ; Vitamin A , Vitamin B 12 , Iron , Zinc , Copper Levels of Children with Lower Respiratory Tract Infections

Iron and vitamin D3 levels in infants admitted with chest infection: A hospital-based study

Serum Micronutrients as related to Childhood Pneumonia Severity and Outcome in a Nigerian Health Facility

Association Between Serum Vitamin A Levels and Recurrent Respiratory Tract Infections in Children

Effect of nutritional status on the course and outcomes of acute respiratory infections in children affecting the lower respiratory tract

Dynamic monitoring and a clinical correlation analysis of the serum vitamin A, D, and E levels in children with recurrent respiratory tract infections.

Recurrent respiratory tract infections in children might be associated with vitamin A status: a case-control study

The Clinical Significance of Serum Vitamin D and Trace Element in Detecting Children with Pneumonia

A Clinical Analysis of Pediatric Recurrent Respiratory Tract Infection

Small and Mighty: Micronutrients at the Intersection of Neonatal Immunity and Infection

Lack of iron, zinc, and vitamins as a contributor to the etiology of atopic diseases

The relationship between IFN-γ, IL-10, IL-6 cytokines, and severity of the condition with serum zinc and Fe in children infected with Mycoplasma pneumoniae

Alt Solunum Yolu Enfeksiyonu Geçiren 1-24 Ay Arası Çocuklarda Serum 25(OH)D Vitamini Düzeyleri

Serum Vitamin D and Zinc Levels in Children with Urinary Tract Infection without Confounding Factors: A Case-Control Study

Meta-analysis of Zn, Cu and Fe in the Hair of Chinese Children with Recurrent Respiratory Tract Infection

Serum zinc levels amongst under-five children with acute diarrhoea and bacterial pathogens

Oral vitamin A supplements to prevent acute upper respiratory tract infections in children up to seven years of age

Serum levels of zinc, folate, and vitamin B12 in healthy children aged 3-12 months: Is routine screening necessary?

Copper and Copper/Zinc Ratio in a Series of Cystic Fibrosis Patients

The Correlations of Serum 25-Hydrovitamin D_3 Level and the Lower Respiratory Infection in Infants

Vitamin D Supplementation and Lower Respiratory Tract Infection in Infants: a Nested Case–control Study